Cerus Corp. (CERS) Enters Into Agreement with EFS for INTERCEPT Blood System Development
Tweet Send to a Friend
Cerus Corporation (NASDAQ: CERS) announced today that it has entered into a collaborative agreement with France's national transfusion service, the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


